Naason Science

Naason Science is a preclinical contract research organization (CRO) headquartered in Cheongju-si, South Korea. The company provides integrated preclinical research services, including specialized disease models, in vitro systems, and in vivo studies for drug discovery and development. Its facilities are AAALAC-accredited, and the organization is particularly noted for its expertise in central nervous system (CNS) models, as well as capabilities in areas such as pain, cardiovascular, ophthalmology, and autoimmune diseases. The company’s operations include customized animal model development, histology services, and safety and toxicity testing, supported by a research team with extensive international experience in pharmaceutical development.

By offering specialized preclinical evaluation, Naason Science assists drug developers in validating candidate technologies through accurate disease modeling and data generation. The company’s approach is designed to improve the translatability of preclinical results, which helps sponsors accelerate decision-making during the early stages of drug development. Its partners include biotech and pharmaceutical companies across Korea, Europe, and Japan, with the firm providing both experimental testing and strategic consulting for therapeutic development programs.